Kim SJ (2021) Global awareness of myocardial infarction symptoms in general population. Korean Circ J 51(12):997–1000. https://doi.org/10.4070/kcj.2021.0320

Article  PubMed  PubMed Central  Google Scholar 

Mechanic OJ, Gavin M, Grossman SA (2023) Acute myocardial infarction. 2022 Aug 8. In: StatPearls. Treasure Island (FL): StatPearls Publishing

Oliveira GB, Avezum A, Roever L (2015) Cardiovascular disease burden: evolving knowledge of risk factors in myocardial infarction and stroke through population-based research and perspectives in global prevention. Front Cardiovasc Med 2:32. https://doi.org/10.3389/fcvm.2015.00032

Article  PubMed  PubMed Central  Google Scholar 

Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, Marcassa C, Quinn T, van Weert H, Task Force on the management of chest pain (2002) Task force on the management of chest pain. Eur Heart J 23(15):1153–76. https://doi.org/10.1053/euhj.2002.3194.

Antoniucci D, Valenti R, Trapani M, Moschi G (1999) Current role of stenting in acute myocardial infarction. Am Heart J 138(2 Pt 2):S147–S152. https://doi.org/10.1016/s0002-8703(99)70335-2

Article  CAS  PubMed  Google Scholar 

Hoole SP, Bambrough P (2020) Recent advances in percutaneous coronary intervention. Heart 106(18):1380–1386. https://doi.org/10.1136/heartjnl-2019-315707. (Epub 2020 Jun 10)

Article  CAS  PubMed  Google Scholar 

Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L (2007) Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 50(5):463–470. https://doi.org/10.1016/j.jacc.2007.06.002. (Epub 2007 Jun 29)

Article  CAS  PubMed  Google Scholar 

De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Díaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW, Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation. Drugeluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med. 2012;172(8):611–21; discussion 621–2. https://doi.org/10.1001/archinternmed.2012.758.

Dehghani P (2017) Bioresorbable polymers and stent devices. Curr Treat Options Cardiovasc Med 19(2):12. https://doi.org/10.1007/s11936-017-0510-1

Article  PubMed  Google Scholar 

Park SJ, Kang SJ, Virmani R, Nakano M, Ueda Y (2012) In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol 59(23):2051–2057. https://doi.org/10.1016/j.jacc.2011.10.909

Article  PubMed  Google Scholar 

Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD (2006) Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47(1):175–181. https://doi.org/10.1016/j.jacc.2005.07.071. (Epub 2005 Dec 1)

Article  PubMed  Google Scholar 

Serruys PW, Daemen J (2007) Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 115(11):1433–9; discussion 1439. https://doi.org/10.1161/CIRCULATIONAHA.106.666826. Epub 2007 Mar 7.

Palmerini T, Biondi-Zoccai G, Della Riva D, Mariani A, Sabaté M, Smits PC, Kaiser C, D’Ascenzo F, Frati G, Mancone M, Genereux P, Stone GW (2014) Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network metaanalysis. J Am Coll Cardiol 63(4):299–307. https://doi.org/10.1016/j.jacc.2013.09.061. (Epub 2013 Nov 6)

Article  CAS  PubMed  Google Scholar 

Kang SH, Park KW, Kang DY, Lim WH, Park KT, Han JK, Kang HJ, Koo BK, Oh BH, Park YB, Kandzari DE, Cohen DJ, Hwang SS, Kim HS (2014) Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. Eur Heart J 35(17):1147–58. https://doi.org/10.1093/eurheartj/eht570. Epub 2014 Jan 23

Serruys PW, Farooq V, Kalesan B, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Wijns W, Morice MC, Di Mario C, Corti R, Antoni D, Sohn HY, Eerdmans P, Rademaker-Havinga T, van Es GA, Meier B, Jüni P, Windecker S (2013) Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. JACC Cardiovasc Interv 6(8):777–789. https://doi.org/10.1016/j.jcin.2013.04.011

Article  PubMed  Google Scholar 

Mridha N, Subhaharan D, Niranjan S, Rashid MK, Psaltis P, Singh K (2019) A meta-analysis of randomized controlled trials to compare long-term clinical outcomes of bioabsorbable polymer and durable polymer drug-eluting stents. Eur Heart J Qual Care Clin Outcomes 5(2):105–113. https://doi.org/10.1093/ehjqcco/qcy036.Erratum.In:EurHeartJQualCareClinOutcomes.2019;5(1):82

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29(372):n71. https://doi.org/10.1136/bmj.n71

Article  Google Scholar 

Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10(10):ED000142. https://doi.org/10.1002/14651858.ED000142

Baber U, Chandiramani R, Mehta SR, Sartori S, Zhang Z, Claessen BE, Briguori C, Sharma S, Dangas G, Mehran R (2021) Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY. Catheter Cardiovasc Interv 97(1):63–71. https://doi.org/10.1002/ccd.28995. (Epub 2020 Jun 10)

Article  PubMed  Google Scholar 

van Geuns RJ, Chun-Chin C, McEntegart MB, Merkulov E, Kretov E, Lesiak M, O’Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG (2022) Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial. EuroIntervention 17(18):1467–1476. https://doi.org/10.4244/EIJ-D-21-00514

Article  PubMed  PubMed Central  Google Scholar 

Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek JJ, Wykrzykowska JJ, Asano T, Kogame N, Takahashi K, Chang CC, de Winter RJ, Serruys PW, Wijns W; Collaborators (2020) Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial. EuroIntervention 15(15):e1366–e1374. https://doi.org/10.4244/EIJ-D-18-00944

de Winter RJ, Katagiri Y, Asano T, Milewski KP, Lurz P, Buszman P, Jessurun GAJ, Koch KT, Troquay RPT, Hamer BJB, Ophuis TO, Wöhrle J, Wyderka R, Cayla G, Hofma SH, Levesque S, Żurakowski A, Fischer D, Kośmider M, Goube P, Arkenbout EK, Noutsias M, Ferrari MW, Onuma Y, Wijns W, Serruys PW (2018) A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial. Lancet 391(10119):431–440. https://doi.org/10.1016/S0140-6736(17)33103-3. (Epub 2017 Dec 5)

Article  PubMed  Google Scholar 

van der Heijden LC, Kok MM, Zocca P, Jessurun GAJ, Schotborgh CE, Roguin A, Benit E, Aminian A, Danse PW, Löwik MM, Linssen GCM, van der Palen J, Doggen CJM, von Birgelen C (2018) Bioresorbable polymer-coated orsiro versus durable polymer-coated resolute Onyx Stents (BIONYX): rationale and design of the randomized TWENTE IV multicenter trial. Am Heart J 198:25–32. https://doi.org/10.1016/j.ahj.2017.12.011. (Epub 2017 Dec 21)

Article  CAS  PubMed  Google Scholar 

Arroyo D, Gendre G, Schukraft S, Kallinikou Z, Müller O, Baeriswyl G, Stauffer JC, Goy JJ, Togni M, Cook S, Puricel S (2017) Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: two-year clinical outcomes of the EVERBIO II trial. Int J Cardiol 243:121–125. https://doi.org/10.1016/j.ijcard.2017.05.053. (Epub 2017 May 12)

Article  PubMed  Google Scholar 

Jiménez VA, Iñiguez A, Baz JA, Valdés M, Ortiz A, Vuilliomenet A, Mainar V, Dudek D, Banai S, Tüller D, Bonnet JL, De Miguel A, Bastos G, Wijns W, Saito S (2016) A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: the CENTURY II high risk ACS substudy. Cardiovasc Revasc Med 17(6):355–361. https://doi.org/10.1016/j.carrev.2016.04.001. (Epub 2016 Apr 19)

Article  PubMed  Google Scholar 

Jinnouchi H, Kuramitsu S, Shinozaki T, Hiromasa T, Kobayashi Y, Morinaga T, Yamaji K, Soga Y, Shirai S, Ando K (2016) Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease. Catheter Cardiovasc Interv 88(5):E132–E138. https://doi.org/10.1002/ccd.26360. (Epub 2015 Dec 28)

Article  PubMed  Google Scholar 

Wijns W, Suttorp MJ, Zagozdzon L, Morice MC, McClean D, Stella P, Donohoe D, Knape C, Ormiston J (2016) Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials. EuroIntervention 12(3):352–355. https://doi.org/10.4244/EIJY15M09_14

Article  PubMed  Google Scholar 

Zbinden R, Piccolo R, Heg D, Roffi M, Kurz DJ, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Franzone A, Eberli F, Jüni P, Windecker S, Pilgrim T (2016) Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent for percutaneous coronary revascularization: 2-year results of the BIOSCIENCE trial. J Am Heart Assoc 5(3):e003255. https://doi.org/10.1161/JAHA.116.003255

Article  PubMed  PubMed Central  Google Scholar 

Kaiser C, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz DJ, Pedrazzini G, Moccetti T, Rickli H, Weilenmann D, Vuillomenet A, Steiner M, Von Felten S, Vogt DR, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, BASKET-PROVE II study group (2015) Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 131(1):74–81. https://doi.org/10.1161/CIRCULATIONAHA.114.013520. Epub 2014 Nov 19.

Xu B, Dou KF, Han YL, Lü SZ, Yang YJ, Huo Y, Wang LF, Chen YD, Wang HC, Li WM, Chen JY, Wang L, Wang Y, Ge JB, Li W, Gao RL (2011) A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Chin Med J (Engl) 124(6):811–816

PubMed  Google Scholar 

Meredith IT, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco DJ (2018) Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. EuroIntervention 13(17):2047–2050. https://doi.org/10.4244/EIJ-D-17-00529

Article  PubMed